Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


06.11.2017

1 Am J Surg
1 Ann Otol Rhinol Laryngol
7 Anticancer Res
6 BMC Cancer
1 Br J Cancer
2 Cancer
1 Cancer Res
1 Clin Cancer Res
5 Dis Esophagus
9 Gastrointest Endosc
3 Head Neck
2 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Clin Endocrinol Metab
2 J Clin Oncol
6 Laryngoscope
1 Ophthal Plast Reconstr Surg
1 PLoS Biol
3 PLoS One
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. SAEKI H, Nakashima Y, Hirose K, Sasaki S, et al
    "Energy-less technique" with mini-clips for recurrent laryngeal nerve lymph node dissection in prone thoracoscopic esophagectomy for esophageal cancer.
    Am J Surg. 2017 Oct 23. pii: S0002-9610(17)31290.
    PubMed     Text format     Abstract available


    Ann Otol Rhinol Laryngol

  2. CUNG TD, Lai W, Svider PF, Hanba C, et al
    Sialendoscopy in the Management of Radioiodine Induced Sialadenitis: A Systematic Review.
    Ann Otol Rhinol Laryngol. 2017;126:768-773.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. OKAMOTO JY, Miyazaki A, Kobayashi JI, Miyamoto S, et al
    Induction and Analysis of Cytotoxic T-Lymphocytes that Recognize Autologous Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:4889-4897.
    PubMed     Text format     Abstract available

  4. GUTSCHENRITTER T, Machiorlatti M, Vesely S, Ahmad B, et al
    Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience.
    Anticancer Res. 2017;37:5019-5025.
    PubMed     Text format     Abstract available

  5. SUGITA Y, Takao K, Uesawa Y, Sakagami H, et al
    Search for New Type of Anticancer Drugs with High Tumor Specificity and Less Keratinocyte Toxicity.
    Anticancer Res. 2017;37:5919-5924.
    PubMed     Text format     Abstract available

  6. OBATA K, Shimo T, Okui T, Matsumoto K, et al
    Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:6119-6123.
    PubMed     Text format     Abstract available

  7. SAKAGAMI H, Uesawa Y, Masuda Y, Tomomura M, et al
    Quantitative Structure-Cytotoxicity Relationship of Newly Synthesized Piperic Acid Esters.
    Anticancer Res. 2017;37:6161-6168.
    PubMed     Text format     Abstract available

  8. UESAWA Y, Sakagami H, Ikezoe N, Takao K, et al
    Quantitative Structure-Cytotoxicity Relationship of Aurones.
    Anticancer Res. 2017;37:6169-6176.
    PubMed     Text format     Abstract available

  9. CHOU PY, Lee MM, Lin SY, Sheu MJ, et al
    Pipoxolan Exhibits Antitumor Activity Toward Oral Squamous Cell Carcinoma Through Reactive Oxygen Species-mediated Apoptosis.
    Anticancer Res. 2017;37:6391-6400.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. ROCHA TAH, Thomaz EBAF, da Silva NC, de Sousa Queiroz RC, et al
    Oral primary care: an analysis of its impact on the incidence and mortality rates of oral cancer.
    BMC Cancer. 2017;17:706.
    PubMed     Text format     Abstract available

  11. LIN MC, Lin YC, Chen ST, Young TH, et al
    Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo.
    BMC Cancer. 2017;17:18.
    PubMed     Text format     Abstract available

  12. XIONG L, Zeng XL, Guo CK, Liu AW, et al
    Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
    BMC Cancer. 2017;17:254.
    PubMed     Text format     Abstract available

  13. GREUTER MJ, Schouten CS, Castelijns JA, de Graaf P, et al
    Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F-FDG-PET-CT and/or diffusion-weighted MRI.
    BMC Cancer. 2017;17:256.
    PubMed     Text format     Abstract available

  14. SONG H, Fang F, Valdimarsdottir U, Lu D, et al
    Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
    BMC Cancer. 2017;17:2.
    PubMed     Text format     Abstract available

  15. NIE X, Tan Z, Ge M
    Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    BMC Cancer. 2017;17:702.
    PubMed     Text format     Abstract available


    Br J Cancer

  16. BAE WJ, Koo BS, Lee SH, Kim JM, et al
    Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
    Br J Cancer. 2017 Nov 2. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  17. HUANG WB, Chan JYW, Liu DL
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2017 Oct 26. doi: 10.1002/cncr.31031.
    PubMed     Text format     Abstract available

  18. SHERMAN EJ, Dunn LA, Ho AL, Baxi SS, et al
    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30861.
    PubMed     Text format     Abstract available


    Cancer Res

  19. GUO T, Sakai A, Afsari B, Considine M, et al
    A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers.
    Cancer Res. 2017;77:5248-5258.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  20. LIN C, Zhang N, Wang Y, Wang Y, et al
    Functional Role of A Novel Long Noncoding RNA TTN-AS1 in Esophageal Squamous Cell Carcinoma Progression and Metastasis.
    Clin Cancer Res. 2017 Nov 3. pii: clincanres.1851.2017.
    PubMed     Text format     Abstract available


    Dis Esophagus

  21. SUN SY, Zhao BQ, Wang J, Mo ZX, et al
    The clinical implications of mean platelet volume and mean platelet volume/platelet count ratio in locally advanced esophageal squamous cell carcinoma.
    Dis Esophagus. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. TIE H, He F, Shen J, Zhang B, et al
    Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017 Oct 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. AL NATOUR RH, Catanzaro A, Zolotarevsky E, DeBenedet AT, et al
    Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
    Dis Esophagus. 2017 Oct 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. WIGHTMAN SC, Posner MC, Patti MG, Ganai S, et al
    Extremes of body mass index and postoperative complications after esophagectomy.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available

  25. ZHANG H, Chen L, Geng Y, Zheng Y, et al
    Modified anastomotic technique for thoracolaparoscopic Ivor-Lewis esophagectomy: early outcomes and technical details.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  26. CHEN WC, Wolfsen H
    Role of radiofrequency ablation in esophageal squamous dysplasia and early neoplasia.
    Gastrointest Endosc. 2017;85:330-331.
    PubMed     Text format    

  27. KOUNTOURAS J, Polyzos SA, Zeglinas C, Tzathas C, et al
    Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort.
    Gastrointest Endosc. 2017;85:462-463.
    PubMed     Text format    

  28. QIN Y, Halland M
    Esophageal self-dilations as a treatment for refractory benign esophageal strictures.
    Gastrointest Endosc. 2017;85:869.
    PubMed     Text format    

  29. NAIK AD, El-Serag HB
    Endoscopic ablation of low-grade dysplasia in Barrett's esophagus: Have all the boxes been checked for us to move on?
    Gastrointest Endosc. 2017;86:130-132.
    PubMed     Text format    

  30. IYER PG
    Endoscopic submucosal dissection in endotherapy for Barrett's esophagus-related dysplasia and neoplasia: An essential or optional technique?
    Gastrointest Endosc. 2017;86:623-625.
    PubMed     Text format    

  31. DAS KK, Falk GW
    Long-term outcomes for cryotherapy in Barrett's esophagus with high-grade dysplasia: just cracking the ice.
    Gastrointest Endosc. 2017;86:633-635.
    PubMed     Text format    

  32. BERTANI H, Frazzoni M, Conigliaro R
    Are we ready to move toward digital image interpretation in Barrett's esophagus surveillance?
    Gastrointest Endosc. 2017;86:847-848.
    PubMed     Text format    

  33. DU C, Linghu E
    Treatment of esophageal submucosal tumors: endoscopic submucosal tunneling dissection versus thoracoscopic enucleation.
    Gastrointest Endosc. 2017;86:925.
    PubMed     Text format    

  34. SIDDIKI H, Fukami N
    Endoscopic submucosal dissection for Barrett's neoplasia: decade of experience, little progress. Is ESD thE-BEST for complex Barrett's neoplasia?
    Gastrointest Endosc. 2017;86:619-622.
    PubMed     Text format    


    Head Neck

  35. CHAN JYW, Wong STS, Wei WI
    Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.
    Head Neck. 2017 Oct 30. doi: 10.1002/hed.24976.
    PubMed     Text format     Abstract available

  36. TAMAKI A, Miles BA, Lango M, Kowalski L, et al
    AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24862.
    PubMed     Text format     Abstract available

  37. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24986.
    PubMed     Text format     Abstract available


    Int J Cancer

  38. RAJENDRA S, Yang T, Xuan W, Sharma P, et al
    Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Int J Cancer. 2017;141:2037-2049.
    PubMed     Text format     Abstract available

  39. SIEW SS, Martinsen JI, Kjaerheim K, Sparen P, et al
    Occupational exposure to wood dust and risk of nasal and nasopharyngeal cancer: A case-control study among men in four nordic countries-With an emphasis on nasal adenocarcinoma.
    Int J Cancer. 2017;141:2430-2436.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  40. YOSHIDA EJ, Luu M, David JM, Kim S, et al
    Facility Volume and Survival in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2017 Sep 28. pii: S0360-3016(17)33938.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab


  41. CORRIGENDUM FOR Letter to the Editor: "Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness".
    J Clin Endocrinol Metab. 2017 Oct 24. doi: 10.1210/jc.2017-02312.
    PubMed     Text format    


    J Clin Oncol

  42. HO AS, Kim S, Tighiouart M, Gudino C, et al
    Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer.
    J Clin Oncol. 2017;35:3601-3609.
    PubMed     Text format     Abstract available

  43. VAN DEN WYNGAERT T, Helsen N, Carp L, Hakim S, et al
    Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
    J Clin Oncol. 2017;35:3458-3464.
    PubMed     Text format     Abstract available


    Laryngoscope

  44. NACHALON Y, Alkan U, Shvero J, Yaniv D, et al
    Assessment of laryngeal cancer in patients younger than 40 years.
    Laryngoscope. 2017 Oct 27. doi: 10.1002/lary.26951.
    PubMed     Text format     Abstract available

  45. RUBIN SJ, Cohen MB, Kirke DN, Qureshi MM, et al
    Comparison of facility type outcomes for oral cavity cancer: Analysis of the national cancer database.
    Laryngoscope. 2017;127:2551-2557.
    PubMed     Text format     Abstract available

  46. IWATA AJ, Williams AM, Taylor AR, Chang SS, et al
    Socioeconomic disparities and comorbidities, not race, affect salivary gland malignancy survival outcomes.
    Laryngoscope. 2017;127:2545-2550.
    PubMed     Text format     Abstract available

  47. ROMANO EB, Wagner JM, Alleman AM, Zhao L, et al
    Fine-needle aspiration with selective use of core needle biopsy of major salivary gland tumors.
    Laryngoscope. 2017;127:2522-2527.
    PubMed     Text format     Abstract available

  48. STARMER HM, Ayoub N, Byward C, Kizner J, et al
    The impact of developing a speech and swallow rehab program: Improving patient satisfaction and multidisciplinary care.
    Laryngoscope. 2017;127:2578-2581.
    PubMed     Text format     Abstract available

  49. CLAYBURGH D, Stott W, Bolognone R, Palmer A, et al
    A randomized controlled trial of corticosteroids for pain after transoral robotic surgery.
    Laryngoscope. 2017;127:2558-2564.
    PubMed     Text format     Abstract available


    Ophthal Plast Reconstr Surg

  50. SILVERMAN NK, Shinder R
    Re: "One-Stage Alternatives to the Hughes Procedure for Reconstruction of Large Lower Eyelid Defects: Surgical Techniques and Outcomes".
    Ophthal Plast Reconstr Surg. 2016;32:315.
    PubMed     Text format    


    PLoS Biol

  51. BRADY LK, Wang H, Radens CM, Bi Y, et al
    Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translation.
    PLoS Biol. 2017;15:e2002623.
    PubMed     Text format     Abstract available


    PLoS One

  52. MEI LL, Wang WJ, Qiu YT, Xie XF, et al
    miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.
    PLoS One. 2017;12:e0185636.
    PubMed     Text format     Abstract available

  53. REID P, Wilson P, Li Y, Marcu LG, et al
    In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status.
    PLoS One. 2017;12:e0186186.
    PubMed     Text format     Abstract available

  54. DOOSTI-IRANI A, Mansournia MA, Rahimi-Foroushani A, Haddad P, et al
    Complications of stent placement in patients with esophageal cancer: A systematic review and network meta-analysis.
    PLoS One. 2017;12:e0184784.
    PubMed     Text format     Abstract available


    Radiother Oncol

  55. OU D, Garberis I, Adam J, Blanchard P, et al
    Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
    Radiother Oncol. 2017 Oct 24. pii: S0167-8140(17)32647.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: